NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
PARIS and CAMBRIDGE, Mass., Sept. 18, 2024 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - the "Company" ) , a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major ...
| Ticker |
Sentiment |
Impact |
|
NBTX
|
Neutral
|
24 %
|
|
JNJ
|
Neutral
|
4 %
|
|
CRYPTO:NANO
|
Neutral
|
2 %
|
